Grant: CIHR Fellowship
University of Calgary
$135,000.00
Strain-typing of Alzheimer's amyloid using advanced fluorescence spectroscopy
FY 2022-23
Summary
A major hallmark of Alzheimer's disease (AD) and related dementias is accumulation of abnormal protein aggregates in the brain. These deposits are made up of improperly shaped (misfolded) proteins forming amyloid plaques and neurofibrillary tangles. Interestingly, similar protein deposits are also found in normal aging without dementia. A key unanswered question is: how can accumulation of the same protein either cause dementia or remain benign as part of the normal aging process? We think that differently-sized and shaped protein aggregates are responsible for very different effects on the brain, some being toxic, others benign. We now know that different types of aggregates formed by the same protein are found in AD and other dementias exhibiting very different symptoms, speed of progression and the severity of cognitive decline. Therefore, different "strains" of aggregates (like different strains of viruses) could account for the many different types of dementia. Importantly, some strains may accumulate in normal aging brains and not cause disease. The focus of this project is to develop tools that can distinguish such strain differences.
It is difficult to detect different misfolded protein strains with current methods. We have developed new techniques that allow us to measure disease-related protein deposits. Using fluorescent dyes that report aggregates by changing the color of light they emit (emission spectrum), we will examine human post-mortem brain sections microscopically from subjects previously diagnosed with specific types of Alzheimer's dementia, as well as aged subjects without dementia who died of unrelated causes. We will correlate spectral patterns with clinical state, with the goal of being able to predict disease subtypes (driven by different strains) from our spectral signatures. Eventually this method could be adapted to diagnose early disease during life from spinal fluid samples, or even blood, which is a major unmet challenge in the field.
Department
Program
CIHR Fellowship
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
472130
Name
Stepanchuk Anastasiia
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Strain-typing of Alzheimer's amyloid using advanced fluorescence spectroscopy
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Amyloid; Dementia; Fluorescence Spectroscopy; Neurodegeneration; Neuropathology; Protein Misfolding; Spectral Microscopy
Abstract
A major hallmark of Alzheimer's disease (AD) and related dementias is accumulation of abnormal protein aggregates in the brain. These deposits are made up of improperly shaped (misfolded) proteins forming amyloid plaques and neurofibrillary tangles. Interestingly, similar protein deposits are also found in normal aging without dementia. A key unanswered question is: how can accumulation of the same protein either cause dementia or remain benign as part of the normal aging process? We think that differently-sized and shaped protein aggregates are responsible for very different effects on the brain, some being toxic, others benign. We now know that different types of aggregates formed by the same protein are found in AD and other dementias exhibiting very different symptoms, speed of progression and the severity of cognitive decline. Therefore, different "strains" of aggregates (like different strains of viruses) could account for the many different types of dementia. Importantly, some strains may accumulate in normal aging brains and not cause disease. The focus of this project is to develop tools that can distinguish such strain differences.
It is difficult to detect different misfolded protein strains with current methods. We have developed new techniques that allow us to measure disease-related protein deposits. Using fluorescent dyes that report aggregates by changing the color of light they emit (emission spectrum), we will examine human post-mortem brain sections microscopically from subjects previously diagnosed with specific types of Alzheimer's dementia, as well as aged subjects without dementia who died of unrelated causes. We will correlate spectral patterns with clinical state, with the goal of being able to predict disease subtypes (driven by different strains) from our spectral signatures. Eventually this method could be adapted to diagnose early disease during life from spinal fluid samples, or even blood, which is a major unmet challenge in the field.
Competitiondate
202210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Stepanchuk, Anastasiia
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~